Allscripts began a strategic partnership with DBMotion in 2009 and made an equity investment in the company in 2011.

Enanta would have an initial market capitalisation of $252m at $15 per share, according to its regulatory filing.

Alongside Celgene and Novo as reinvestors in PTC are Investment bank Credit Suisse and fund managers HBM Healthcare Investments, Vulcan Capital, Delphi Ventures and Column Group.

Swallow Solutions, a spin out of the University of Wisconsin, raises $1m in a series A round led by Venture Management.

In September 2011, CardioKinetix closed a two tranche round of series E financing worth $44m, led by venture capital (VC) firms SV Life Sciences and New Leaf Venture Partners.

The HighLife deal is seen by Sorin as a complement to its investment in Cardiosolutions, which is developing an innovative percutaneous mitral repair system.?

In addition, Sorin is investing $5m in Rainbow Medical, an Israeli medical device incubator of 10 startups founded by Yossi Gross and owner of Enopace.

New investors Norwest Venture Partners were joined by Kleiner Perkins and Medtronic in a $30m D round for US-based medical device company Intersect ENT.